David Bing Zhen, MD
Fred Hutchinson Cancer Center/University of Washington
Topic Presenter
Biography
Dr. David Zhen is an Associate Professor of Medicine at the Fred Hutchinson Cancer Research Center and University of Washington. He is a gastrointestinal medical oncologist and cares for patients with all gastrointestinal malignancies but has a specific clinical and research focus in neuroendocrine tumors and gastroesophageal cancers. He is the Co-Director of the Neuroendocrine Tumor Program and also oversees the research program for gastroesophageal cancers at his institution. His research is focused on identifying new therapies through clinical trials incorporating translational research with the goal of identifying biomarkers that better predict response and resistance to therapy, particularly related to immunotherapy. He is the national and local PI for investigator-initiated and industry-sponsored clinical trials in neuroendocrine and gastroesophageal cancers and serves on several national committees including being a panel member of the NCCN Neuroendocrine and Adrenal Guidelines, Early Career Member of the NCI Neuroendocrine Task Force, and serves other roles within SWOG and the NCI cooperative group system.
Financial Disclosure
AstraZeneca
, Cambridge, Cambridgeshire, England
Professional Service
Jazz Pharmaceuticals
3000 El Camino Real, 2 Palo Alto Square, Suite 600, Palo Alto, California, USA
Professional Service
Roche/Genentech
Professional Service
Merck
Professional Service
Ipsen
Professional Service
Bayer
Professional Service
Daiichi Sankyo, Inc
Professional Service
Eli Lilly
Professional Service
Bristol Meyers Squibb
Professional Service
Jazz Pharmaceuticals/Zymeworks, Inc
Independent Contractor
A2 Biotherapies
Professional Service
Excelixis
Professional Service
Medigene
Professional Service
Cornerstone Pharmaceuticals
Professional Service
Legend Biotech
Professional Service
Pfizer/Seagen
Professional Service